Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Leukemia

Clinical Trial at: Arizona Oncology - Tucson

An Open Label Compassionate Use Trial of Ublituximab and/or Umbralisib (TGR-1202) in Combination with other Novel Agents or as Single Agents in Subjects Currently Receiving Treatment on a TG Therapeutics Study (UTX-TGR-501)

  • Details

ClinicalTrials.gov ID: NCT03207256
Diagnosis Type: CLL
USOR Number: 19198

  • Practice Details

603 N Wilmot Rd, Suite 151
Tucson, AZ 85711
P: (520) 886-0206

More Details View Practice Page

Leukemia

Clinical Trial at: Texas Oncology - New Braunfels

An Open Label Compassionate Use Trial of Ublituximab and/or Umbralisib (TGR-1202) in Combination with other Novel Agents or as Single Agents in Subjects Currently Receiving Treatment on a TG Therapeutics Study (UTX-TGR-501)

  • Details

ClinicalTrials.gov ID: NCT03207256
Diagnosis Type: CLL
USOR Number: 19198

  • Practice Details

1448 East Common St
New Braunfels, TX 78130
P: (830) 643-1762

More Details View Practice Page

Leukemia

Clinical Trial at: Texas Oncology - Denton

An Open Label Compassionate Use Trial of Ublituximab and/or Umbralisib (TGR-1202) in Combination with other Novel Agents or as Single Agents in Subjects Currently Receiving Treatment on a TG Therapeutics Study (UTX-TGR-501)

  • Details

ClinicalTrials.gov ID: NCT03207256
Diagnosis Type: CLL
USOR Number: 19198

  • Practice Details

3720 South I-35 East
Denton, TX 76210
P: (940) 382-1022

More Details View Practice Page

Leukemia

Clinical Trial at: Texas Oncology - San Antonio

An Open Label Compassionate Use Trial of Ublituximab and/or Umbralisib (TGR-1202) in Combination with other Novel Agents or as Single Agents in Subjects Currently Receiving Treatment on a TG Therapeutics Study (UTX-TGR-501)

  • Details

ClinicalTrials.gov ID: NCT03207256
Diagnosis Type: CLL
USOR Number: 19198

  • Practice Details

5206 Research Dr
San Antonio, TX 75204
P: (210) 595-5300

More Details View Practice Page

Leukemia

Clinical Trial at: Minnesota Oncology - Coon Rapids

An Open Label Compassionate Use Trial of Ublituximab and/or Umbralisib (TGR-1202) in Combination with other Novel Agents or as Single Agents in Subjects Currently Receiving Treatment on a TG Therapeutics Study (UTX-TGR-501)

  • Details

ClinicalTrials.gov ID: NCT03207256
Diagnosis Type: CLL
USOR Number: 19198

  • Practice Details

11850 Blackfoot St NW, Suite 100
Coon Rapids, MN 55433
P: (763) 712-2100

More Details View Practice Page

Lung Cancer

Clinical Trial at: Virginia Cancer Specialists - Leesburg

A Phase III, Randomized, Double-Blind, Placebo-controlled study of Atezolizumab plus Carboplatin and Etoposide with or without Tiragolumab (Anti-Tigit Antibody) in patients with untreated extensive-stage small cell lung cancer (GO41767)

  • Details

ClinicalTrials.gov ID: NCT04256421
Diagnosis Type: NA
USOR Number: 19193

  • Practice Details

44035 Riverside Parkway, Suite 300
Leesburg, VA 20176
P: (703) 554-6800

More Details View Practice Page

Lung Cancer

Clinical Trial at: 19193-Lung Cancer-NA-1553 -

A Phase III, Randomized, Double-Blind, Placebo-controlled study of Atezolizumab plus Carboplatin and Etoposide with or without Tiragolumab (Anti-Tigit Antibody) in patients with untreated extensive-stage small cell lung cancer (GO41767)

  • Details

ClinicalTrials.gov ID: NCT04256421
Diagnosis Type: NA
USOR Number: 19193

  • Practice Details


,
P:

More Details View Practice Page

Lung Cancer

Clinical Trial at: 19193-Lung Cancer-NA-632 -

A Phase III, Randomized, Double-Blind, Placebo-controlled study of Atezolizumab plus Carboplatin and Etoposide with or without Tiragolumab (Anti-Tigit Antibody) in patients with untreated extensive-stage small cell lung cancer (GO41767)

  • Details

ClinicalTrials.gov ID: NCT04256421
Diagnosis Type: NA
USOR Number: 19193

  • Practice Details


,
P:

More Details View Practice Page

Lung Cancer

Clinical Trial at: Comprehensive Cancer Centers of Nevada - Las Vegas

A Phase III, Randomized, Double-Blind, Placebo-controlled study of Atezolizumab plus Carboplatin and Etoposide with or without Tiragolumab (Anti-Tigit Antibody) in patients with untreated extensive-stage small cell lung cancer (GO41767)

  • Details

ClinicalTrials.gov ID: NCT04256421
Diagnosis Type: NA
USOR Number: 19193

  • Practice Details

3730 S Eastern Ave
Las Vegas, NV 89169
P: (702) 952-3400

More Details View Practice Page

Lung Cancer

Clinical Trial at: 19193-Lung Cancer-NA-491 -

A Phase III, Randomized, Double-Blind, Placebo-controlled study of Atezolizumab plus Carboplatin and Etoposide with or without Tiragolumab (Anti-Tigit Antibody) in patients with untreated extensive-stage small cell lung cancer (GO41767)

  • Details

ClinicalTrials.gov ID: NCT04256421
Diagnosis Type: NA
USOR Number: 19193

  • Practice Details


,
P:

More Details View Practice Page
1 2 3 330